DK1140139T4 - Anvendelse af erythropoietin eller erythropoietinderivater til behandling af cerebrale iskræmier - Google Patents

Anvendelse af erythropoietin eller erythropoietinderivater til behandling af cerebrale iskræmier

Info

Publication number: DK1140139T4
Authority: DK; Denmark
Prior art keywords: erythropoietin; cerebral; treatment; ischaemia; derivatives
Prior art date: 1998-12-14

Application number

DK99966958T

Other languages

English (en)

Other versions

DK1140139T3 (da

Inventor

Hannelore Ehrenreich

Christoph Gleiter

Original Assignee

Christoph Gleiter

Hannelore Ehrenreich

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-14

Filing date

1999-12-13

Publication date

2009-06-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7891015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1140139(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-12-13 Application filed by Christoph Gleiter, Hannelore Ehrenreich filed Critical Christoph Gleiter

2004-03-15 Publication of DK1140139T3 publication Critical patent/DK1140139T3/da

2009-06-08 Application granted granted Critical

2009-06-08 Publication of DK1140139T4 publication Critical patent/DK1140139T4/da

Links

OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 5
102000003951 Erythropoietin Human genes 0.000 title abstract 4
108090000394 Erythropoietin Proteins 0.000 title abstract 4
229940105423 erythropoietin Drugs 0.000 title abstract 4
230000002490 cerebral effect Effects 0.000 title abstract 3
235000015243 ice cream Nutrition 0.000 title 1
206010008120 Cerebral ischaemia Diseases 0.000 abstract 3
208000006011 Stroke Diseases 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
208000028867 ischemia Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000002093 peripheral effect Effects 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

DK99966958T 1998-12-14 1999-12-13 Anvendelse af erythropoietin eller erythropoietinderivater til behandling af cerebrale iskræmier DK1140139T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19857609A DE19857609A1 (de)	1998-12-14	1998-12-14	Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
PCT/EP1999/009864 WO2000035475A2 (de)	1998-12-14	1999-12-13	Verfahren zur behandlung von cerebralen ischämien sowie verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien

Publications (2)

Publication Number	Publication Date
DK1140139T3 DK1140139T3 (da)	2004-03-15
DK1140139T4 true DK1140139T4 (da)	2009-06-08

Family

ID=7891015

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99966958T DK1140139T4 (da)	1998-12-14	1999-12-13	Anvendelse af erythropoietin eller erythropoietinderivater til behandling af cerebrale iskræmier

Country Status (26)

Country	Link
US (1)	US7514072B1 (da)
EP (1)	EP1140139B2 (da)
JP (2)	JP4750947B2 (da)
KR (1)	KR100774827B1 (da)
CN (1)	CN1187085C (da)
AT (1)	ATE253932T1 (da)
AU (1)	AU766216C (da)
BG (1)	BG65417B1 (da)
BR (1)	BR9916197A (da)
CA (1)	CA2353553C (da)
DE (2)	DE19857609A1 (da)
DK (1)	DK1140139T4 (da)
ES (1)	ES2211218T5 (da)
HK (1)	HK1042655B (da)
HU (1)	HUP0104709A3 (da)
ID (1)	ID29107A (da)
IL (2)	IL143579A0 (da)
MX (1)	MXPA01005971A (da)
NO (1)	NO330079B1 (da)
NZ (1)	NZ541591A (da)
PL (1)	PL202483B1 (da)
PT (1)	PT1140139E (da)
RO (1)	RO121409B1 (da)
RU (1)	RU2242991C2 (da)
WO (1)	WO2000035475A2 (da)
ZA (1)	ZA200104626B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19857609A1 (de)	1998-12-14	2000-06-15	Hannelore Ehrenreich	Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
US7410941B1 (en)	1999-04-13	2008-08-12	The Kenneth S. Warren Institute, Inc.	Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
CA2383940A1 (en) *	1999-04-13	2000-10-19	The Kenneth S. Warren Laboratories, Inc.	Modulation of excitable tissue function by peripherally administered erythropoietin
US7345019B1 (en)	1999-04-13	2008-03-18	The Kenneth S. Warren Institute, Inc.	Modulation of excitable tissue function by peripherally administered erythropoietin
US7078376B1 (en)	2000-08-11	2006-07-18	Baxter Healthcare S.A.	Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
DE10043457A1 (de) *	2000-09-04	2002-03-28	Hannelore Ehrenreich	Verfahren zur Behandlung von Schizophrenie und verwandten Psychosen sowie Verwendung von Erythropoietin oder Erythropoietinderivaten zur Behandlung von Schizophrenien und verwandten Psychosen
US6531121B2 (en)	2000-12-29	2003-03-11	The Kenneth S. Warren Institute, Inc.	Protection and enhancement of erythropoietin-responsive cells, tissues and organs
PA8536201A1 (es) *	2000-12-29	2002-08-29	Kenneth S Warren Inst Inc	Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
US7767643B2 (en)	2000-12-29	2010-08-03	The Kenneth S. Warren Institute, Inc.	Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en)	2000-12-29	2003-04-17	Michael Brines	Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
EP1423509A2 (en)	2001-08-30	2004-06-02	Stem Cell Therapeutics Inc.	Differentiation of neural stem cells and therapeutic use thereof
US7393830B2 (en)	2001-09-14	2008-07-01	Stem Cell Therapeutics Inc.	Prolactin induced increase in neural stem cell numbers
DE10219545A1 (de) *	2002-04-26	2003-11-06	Lang Florian	Regulation der Apoptose
CA2488497A1 (en) *	2002-06-11	2003-12-18	The Burnham Institute	Neuroprotective synergy of erythropoietin and insulin-like growth factor
DE10234192B4 (de)	2002-07-26	2009-11-26	Epoplus Gmbh Co.Kg	Verwendung von Erythropoetin
WO2004087063A2 (en) *	2003-03-27	2004-10-14	Janssen Pharmaceutica Nv	Use of erythropoietin in stroke recovery
US7718363B2 (en)	2003-04-25	2010-05-18	The Kenneth S. Warren Institute, Inc.	Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
US20070111932A1 (en) *	2003-07-31	2007-05-17	Stem Cell Therapeutics Inc.	Method of enhancing and/or inducing neuronal migration using erythropoietin
JP2007517769A (ja)	2003-09-29	2007-07-05	ウォーレンファーマシューティカルズ，インコーポレーテッド	敗血症および癒着形成の治療および予防のための組織保護性サイトカイン
BRPI0415531B8 (pt) *	2003-10-23	2021-05-25	Otsuka Pharma Co Ltd	formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
JP4990634B2 (ja) *	2004-02-13	2012-08-01	ステムセルセラピューティクスコーポレイション	神経幹細胞の増殖および神経発生のための黄体化ホルモン（ＬＨ）、および絨毛性ゴナドトロピン（ｈＣＧ）の使用
US9988427B2 (en)	2005-05-13	2018-06-05	Charite Universitaetsmedizen-Berlin	Erythropoietin variants
EP1736481A1 (en)	2005-05-13	2006-12-27	Charite Universitätsmedizin-Berlin	Erythropoietin variants
CA2622758A1 (en) *	2005-09-15	2007-03-29	Elan Pharma International, Limited	Nanoparticulate aripiprazole formulations
JP2009509943A (ja)	2005-09-27	2009-03-12	ステムセルセラピューティクスコーポレイション	プロラクチンにより制御される乏突起膠細胞前駆体細胞の増殖
CA2644116A1 (en)	2006-03-17	2007-09-27	Stem Cell Therapeutics Corp.	Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
AU2007255717B2 (en) *	2006-06-07	2013-07-11	Chugai Seiyaku Kabushiki Kaisha	Treatment of ischemic disease using erythropoietin
JP4879349B2 (ja)	2007-07-31	2012-02-22	大塚製薬株式会社	アリピプラゾール懸濁液及び凍結乾燥製剤の製造方法
RU2446834C2 (ru) *	2010-06-15	2012-04-10	Елена Александровна Лебедева	Способ лечения пострадавших с сочетанной черепно-мозговой травмой
WO2012148200A2 (ko)	2011-04-26	2012-11-01	아주대학교 산학협력단	허혈성 혈관 질환 치료시술 보조용 조성물
RU2495688C1 (ru) *	2012-03-28	2013-10-20	Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии"	Способ лечения ишемии головного мозга в эксперименте
US9610444B2 (en)	2013-03-15	2017-04-04	Pacesetter, Inc.	Erythropoeitin production by electrical stimulation
KR20190052855A (ko)	2017-11-09	2019-05-17	대한제당 주식회사	페길레이션된 에리스로포이에틴을 포함하는 허혈성 뇌질환 치료용 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ210501A (en)	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS6197229A (ja)	1984-10-18	1986-05-15	Chugai Pharmaceut Co Ltd	安定なエリトロポエチン製剤
IL77081A (en)	1984-12-04	1999-10-28	Genetics Inst	Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US5013718A (en) *	1986-11-21	1991-05-07	Amgen, Inc.	Method for treating iron overload using EPO
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
ATE174058T1 (de)	1989-11-06	1998-12-15	Cell Genesys Inc	Herstellung von proteinen mittels homologer rekombination
HU217212B (hu)	1989-12-22	1999-12-28	Applied Research Systems, ARS Holding M.V.	Endogén gének expressziójának módosítása szabályozóelemmel
US5750376A (en)	1991-07-08	1998-05-12	Neurospheres Holdings Ltd.	In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
PT101031B (pt)	1991-11-05	2002-07-31	Transkaryotic Therapies Inc	Processo para o fornecimento de proteinas por terapia genetica
US5641670A (en)	1991-11-05	1997-06-24	Transkaryotic Therapies, Inc.	Protein production and protein delivery
JP3537151B2 (ja)	1991-12-26	2004-06-14	中外製薬株式会社	脳機能障害による疾患の予防・治療薬
RU2068268C1 (ru) *	1992-03-19	1996-10-27	Учебно-научный центр Медицинского центра при Правительстве РФ	Способ профилактики церебро-васкулярных заболеваний
US5614184A (en)	1992-07-28	1997-03-25	New England Deaconess Hospital	Recombinant human erythropoietin mutants and therapeutic methods employing them
US5661125A (en)	1992-08-06	1997-08-26	Amgen, Inc.	Stable and preserved erythropoietin compositions
TW402639B (en)	1992-12-03	2000-08-21	Transkaryotic Therapies Inc	Protein production and protein delivery
CN1125401A (zh)	1993-04-29	1996-06-26	艾博特公司	促红细胞生成素类似物组合物和方法
IL192290A0 (en)	1993-08-17	2008-12-29	Kirin Amgen Inc	Erythropoietin analogs
SE520730C2 (sv)	1995-01-20	2003-08-19	Eskil Elmer	Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel
US6121246A (en)	1995-10-20	2000-09-19	St. Elizabeth's Medical Center Of Boston, Inc.	Method for treating ischemic tissue
US6165783A (en)	1997-10-24	2000-12-26	Neuro Spheres Holdings Ltd.	Erythropoietin-mediated neurogenesis
DE19857609A1 (de)	1998-12-14	2000-06-15	Hannelore Ehrenreich	Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
CA2383940A1 (en)	1999-04-13	2000-10-19	The Kenneth S. Warren Laboratories, Inc.	Modulation of excitable tissue function by peripherally administered erythropoietin
US20030072737A1 (en)	2000-12-29	2003-04-17	Michael Brines	Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs

1998
- 1998-12-14 DE DE19857609A patent/DE19857609A1/de not_active Ceased
1999
- 1999-12-13 CN CNB998160474A patent/CN1187085C/zh not_active Expired - Fee Related
- 1999-12-13 EP EP99966958A patent/EP1140139B2/de not_active Expired - Lifetime
- 1999-12-13 ES ES99966958T patent/ES2211218T5/es not_active Expired - Lifetime
- 1999-12-13 BR BR9916197-4A patent/BR9916197A/pt not_active Application Discontinuation
- 1999-12-13 CA CA2353553A patent/CA2353553C/en not_active Expired - Fee Related
- 1999-12-13 RU RU2001116077/14A patent/RU2242991C2/ru not_active IP Right Cessation
- 1999-12-13 HU HU0104709A patent/HUP0104709A3/hu unknown
- 1999-12-13 PT PT99966958T patent/PT1140139E/pt unknown
- 1999-12-13 PL PL349335A patent/PL202483B1/pl not_active IP Right Cessation
- 1999-12-13 US US09/868,089 patent/US7514072B1/en not_active Expired - Fee Related
- 1999-12-13 DK DK99966958T patent/DK1140139T4/da active
- 1999-12-13 AU AU22831/00A patent/AU766216C/en not_active Ceased
- 1999-12-13 WO PCT/EP1999/009864 patent/WO2000035475A2/de not_active Ceased
- 1999-12-13 RO ROA200100684A patent/RO121409B1/ro unknown
- 1999-12-13 AT AT99966958T patent/ATE253932T1/de active
- 1999-12-13 ID IDW00200101535A patent/ID29107A/id unknown
- 1999-12-13 DE DE59907752T patent/DE59907752D1/de not_active Expired - Lifetime
- 1999-12-13 KR KR1020017007421A patent/KR100774827B1/ko not_active Expired - Fee Related
- 1999-12-13 HK HK02104485.2A patent/HK1042655B/zh not_active IP Right Cessation
- 1999-12-13 JP JP2000587794A patent/JP4750947B2/ja not_active Expired - Fee Related
- 1999-12-13 MX MXPA01005971A patent/MXPA01005971A/es active IP Right Grant
- 1999-12-13 NZ NZ541591A patent/NZ541591A/en not_active IP Right Cessation
- 1999-12-13 IL IL14357999A patent/IL143579A0/xx active IP Right Grant
2001
- 2001-06-05 IL IL143579A patent/IL143579A/en not_active IP Right Cessation
- 2001-06-06 ZA ZA200104626A patent/ZA200104626B/en unknown
- 2001-06-07 BG BG105575A patent/BG65417B1/bg unknown
- 2001-06-12 NO NO20012896A patent/NO330079B1/no not_active IP Right Cessation
2010
- 2010-12-20 JP JP2010283105A patent/JP2011079860A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
BR9916197A (pt)	2001-09-04
DE19857609A1 (de)	2000-06-15
WO2000035475A2 (de)	2000-06-22
NO20012896L (no)	2001-08-14
PT1140139E (pt)	2004-04-30
US7514072B1 (en)	2009-04-07
RU2242991C2 (ru)	2004-12-27
CA2353553A1 (en)	2000-06-22
EP1140139B1 (de)	2003-11-12
NO330079B1 (no)	2011-02-14
ES2211218T5 (es)	2009-06-03
CN1187085C (zh)	2005-02-02
ES2211218T3 (es)	2004-07-01
JP2002532432A (ja)	2002-10-02
HUP0104709A3 (en)	2002-05-28
ID29107A (id)	2001-07-26
EP1140139B9 (de)	2004-03-31
HUP0104709A2 (hu)	2002-04-29
AU766216B2 (en)	2003-10-09
EP1140139B2 (de)	2009-03-18
IL143579A (en)	2007-10-31
BG65417B1 (bg)	2008-07-31
CN1335776A (zh)	2002-02-13
ATE253932T1 (de)	2003-11-15
MXPA01005971A (es)	2002-03-27
CA2353553C (en)	2011-05-17
NO20012896D0 (no)	2001-06-12
AU766216C (en)	2004-11-11
DK1140139T3 (da)	2004-03-15
BG105575A (en)	2002-01-31
RO121409B1 (ro)	2007-05-30
HK1042655B (zh)	2005-09-23
PL202483B1 (pl)	2009-06-30
HK1042655A1 (en)	2002-08-23
PL349335A1 (en)	2002-07-15
WO2000035475A3 (de)	2000-10-19
AU2283100A (en)	2000-07-03
KR20010082346A (ko)	2001-08-29
DE59907752D1 (de)	2003-12-18
JP2011079860A (ja)	2011-04-21
JP4750947B2 (ja)	2011-08-17
ZA200104626B (en)	2002-09-06
NZ541591A (en)	2007-08-31
KR100774827B1 (ko)	2007-11-07
EP1140139A2 (de)	2001-10-10
IL143579A0 (en)	2002-04-21

Publication	Publication Date	Title
DK1140139T3 (da)	2004-03-15	Anvendelse af erythropoietin eller erythropoietinderivater til behandling af cerebrale iskræmier
EP4442241A3 (en)	2024-12-25	Retinol replacement in skin treatment
EA200800056A1 (ru)	2008-06-30	Каннабиноидный активный фармацевтический ингредиент для лекарственных форм
DK1289517T3 (da)	2006-04-03	Farmaceutiske sammensætninger indeholdende cannabidiolderivater
WO2004096216A3 (en)	2005-04-14	Use of a topical medicament comprising riluzole
ES2157005T3 (es)	2001-08-01	Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina.
DK0832081T3 (da)	2003-05-26	Bicykliske-aromatiske forbindelser
WO2004100893A3 (en)	2005-07-28	Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
WO2007046097A3 (en)	2009-04-09	Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
ATE141045T1 (de)	1996-08-15	Schlankmachende zusammensetzung
NZ328874A (en)	1999-06-29	Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
FR2746098B1 (fr)	1998-04-30	Composes propynyl biaromatiques
BR0310061A (pt)	2005-03-01	Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
HUP0000386A1 (hu)	2000-12-28	Adamantánaminok és szerkezetileg hasonló vegyületek alkalmazása borna-betegséget okozó vírus leküzdésére, valamint kedélybetegségek és más, a borna-betegséget okozó vírusfertőzéssel kapcsolatos zavarok megelőzésére és kezelésére
DE60336756D1 (de)	2011-05-26	Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
DE60306503D1 (de)	2006-08-10	Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
HUP0204180A2 (hu)	2003-04-28	Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
KR102163775B9 (ko)	2022-07-18	7-벤질-4-7H-피롤로[2,3-d]피리미딘 유도체 및 이를 유효성분으로 함유하는 피부 미백용 조성물 및 멜라닌 색소 과다 침착 질환의 예방 또는 치료용 약학적 조성물
DE60003074D1 (de)	2003-07-03	Fusidinsäure-derivate
NO20021241L (no)	2002-03-13	Farmasöytiske og/eller kosmetiske blandinger
IS7418A (is)	2004-08-20	Sítalópram til að meðhöndla hækkaðan blóðþrýsting
ATE406888T1 (de)	2008-09-15	Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern
BR0312283A (pt)	2005-04-12	Combinação compreendendo um agente de alquilação e um agente redutor da atividade de vegf
IT1310326B1 (it)	2002-02-13	Pomata per la cura delle lesioni cutanee particolarmente delle ustioni
BR0214644A (pt)	2004-11-03	Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação